Polyrizon (PLRZ) News
NASDAQ: PLRZHealth CareMedical/Dental InstrumentsUSD
9.31-0.8557 (-8.42%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PLRZ news summary
We found 2 recent headlines mentioning Polyrizon (PLRZ): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire. PLRZ is making an outsized move today, down 8.42% at $9.31, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "POLYRIZON ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN", was published by GlobeNewswire on Nov 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Polyrizon headlines
- POLYRIZON ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLANTEL AVIV, Israel, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech company specializing in the development of innovative…GlobeNewswire
- Polyrizon Announces Successful Completion Enrollment of all 120 Patients in U.S. Clinical Study of NASARIX Allergy BlockerAll 120 planned participants randomized across five clinical sites in the United StatesGlobeNewswire